Cargando…
Mercaptobenzimidazole-Based 1,3-Thaizolidin-4-ones as Antidiabetic Agents: Synthesis, In Vitro α-Glucosidase Inhibition Activity, and Molecular Docking Studies
[Image: see text] In this research work, we have focused our efforts to synthesize a series of 2-mercaptobenzimidazole-based 1,3-thiazolidin-4-ones (5–24) following a multistep reaction strategy and characterization of the synthesized derivatives with the help of various spectroscopic techniques. To...
Autores principales: | Khan, Sher Ali, Ali, Mumtaz, Latif, Abdul, Ahmad, Manzoor, Khan, Ajmal, Al-Harrasi, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386811/ https://www.ncbi.nlm.nih.gov/pubmed/35990459 http://dx.doi.org/10.1021/acsomega.2c01969 |
Ejemplares similares
-
Novel 5-(Arylideneamino)-1H-Benzo[d]imidazole-2-thiols as
Potent Anti-Diabetic
Agents: Synthesis, In Vitro α-Glucosidase Inhibition,
and Molecular Docking Studies
por: Ali, Sardar, et al.
Publicado: (2022) -
Meldrum-Based-1H-1,2,3-Triazoles
as Antidiabetic Agents: Synthesis, In Vitro α-Glucosidase
Inhibition Activity, Molecular Docking Studies, and In Silico Approach
por: Avula, Satya Kumar, et al.
Publicado: (2023) -
Bio-Oriented Synthesis of Novel Polyhydroquinoline
Derivatives as α-Glucosidase Inhibitor for Management
of Diabetes
por: Talab, Faiz, et al.
Publicado: (2023) -
2-Mercaptobenzimidazole clubbed hydrazone for Alzheimer’s therapy: In vitro, kinetic, in silico, and in vivo potentials
por: Begum, Farida, et al.
Publicado: (2022) -
Synthesis, Bioactivity Assessment, and Molecular Docking of Non-sulfonamide
Benzimidazole-Derived N-Acylhydrazone Scaffolds
as Carbonic Anhydrase-II Inhibitors
por: Saadiq, Muhammad, et al.
Publicado: (2021)